H. Nomura et al., HEPATITIS-C VIRUS-RELATED LIVER-DAMAGE IS RELATED TO COLD ACTIVATION OF COMPLEMENT, Journal of clinical gastroenterology, 25(3), 1997, pp. 529-534
A high positivity of cold activation of complement has been reported i
n Japanese patients having hepatitis B virus-negative chronic hepatiti
s. Although the cause of cold activation of complement is unknown, the
involvement of hepatitis C virus (HCV) has been suspected. We studied
the positivity of cold activation of complement in 253 patients, incl
uding 93 patients with chronic hepatitis C infection who received 6MU
natural interferon-cx per day for 24 continuous weeks. Cold activation
was positive in 38% of patients with chronic hepatitis C and in 46% o
f patients with liver cirrhosis C. We did not detect cold activation i
n asymptomatic HCV carriers; patients with chronic hepatitis B, liver
cirrhosis B, or alcohol-related liver damage; or in the controls. Cold
activation was also negative in HCV-RNA-negative patients who respond
ed completely to interferon-alpha, and in HCV-RNA-positive patients wh
o responded partially whose serum alanine transaminase levels were nor
malized after interferon treatment. In the patients who had a relapse
of hepatitis C after interferon treatment, positivity of cold activati
on increased sharply. We conclude that HCV-associated liver damage is
related to the development of cold activation of complement. Cold acti
vation is useful for monitoring the response to interferon in patients
with chronic hepatitis C infection.